Endpoints News· @endpts · X·· 2026-10-17精选AI 评分58
AI 导读
City Therapeutics完成2亿美元IPO定价,公司由Alnylam前员工领导,目标是打造RNAi领域的Alnylam 2.0。报道链接指向Endpoints News的相关文章。
推荐理由
由Alnylam前员工创办的RNAi公司完成2亿美元IPO,可观察资本对这一技术路线的定价。
正文
City Therapeutics, led by Alnylam alumni, priced a $200M IPO as it sets out to build an Alnylam 2.0 in RNAi.
https://endpoints.news/city-therapeutics-lands-200m-ipo-as-it-builds-an-alnylam-2-0-in-rnai-field/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com